REBECCA OLSON: Open Payments
NPI 1013203603 · WINNER, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$159 in 9 payments from 4 companies in 2025. Trend: 2023 $130 · 2024 $115 · 2025 $159
Food & beverage: $159
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $94 |
| Novo Nordisk Inc | 2 | $31 |
| Astellas Pharma US Inc | 1 | $19 |
| Amgen Inc. | 1 | $15 |
Products named: MOUNJARO, ZEPBOUND, Veozah, Ozempic, EVENITY, Rybelsus.
Industry payments across SD — which companies pay providers there.
